Czechia· CZ-0242270
LINEZOLID ACCORD
A linezolid product, registered in Czechia by ACCORD HEALTHCARE POLSKA Sp. z o.o., Varšava. The same ATC class is registered in 19 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Linezolid is registered in 19 of 19 countries.
Countries holding a registration under ATC J01XX08 (linezolid), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 11 of them publish a price we can compare per daily dose
Linezolid · ATC J01XX08
19 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of linezolid costs, country by country.
Normalised to the WHO defined daily dose (1.2 g), so markets compare like for like.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Linezolid · price per daily dose (1.2 g)
USD · FX 28 Sept 2026
- CH Switzerland$125.76
- IT Italy$109.29
The record
At a glance
SÚKL (Czech Republic)- Manufacturer
- ACCORD HEALTHCARE POLSKA Sp. z o.o., Varšava
- Country
- Czechia (CZ)
- ATC code
- J01XX08
- ATC class
- Linezolid
- Defined daily dose
- 1.2 g, O
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- August 24, 2026
Packs & prices · 1
1 priced- cz_kod_sukl024227010X300MLCZK 16068.4
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
393 interactions on record for linezolid.
Graded by severity as the source publishes them — 69 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Linezolid · interactions on record
393 records
- 69 severe
- 196 moderate
- 116 info
Most severe, free to view
- IsomethepteneA03AX10severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- DolasetronA04AA04severe
12 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under J01XX08
Linezolid, as other registers publish it.
- CanadaAPO-LINEZOLIDAPOTEX INC
- PolandDilizolenGlenmark Pharmaceuticals s.r.o.
- NetherlandsDilizolen 2 mg/ml, oplossing voor infusieGlenmark Pharmaceuticals s.r.o.
- CanadaJAMP LINEZOLIDJAMP PHARMA CORPORATION
- United StateslinezolidChartwell RX, LLC
- United StatesLinezolidMylan Pharmaceuticals Inc.
- United StatesLinezolidSun Pharmaceutical Industries, Inc.
- United StatesLinezolidAmerican Health Packaging
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e00f15f9-a629-4d46-be47-68738ac24981 GET /v1/drugs/e00f15f9-a629-4d46-be47-68738ac24981?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "INF SOL",
"source": "sukl",
"strength": "2MG/ML",
"pack_size": "10X300ML",
"substance": "15392",
"cz_kod_sukl": "0242270",
"product_type": "CH",
"registration_state": "R",
"registration_number": "15/126/17-C"
}See everything about linezolid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.